Skip to content

Carbohydrates and Related Biomarkers

A Feeding Study to Examine the Effect of Glycemic Load and Obesity on Cancer Biomarkers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00622661
Acronym
CARB
Enrollment
89
Registered
2008-02-25
Start date
2006-06-30
Completion date
2010-07-31
Last updated
2012-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Overweight

Keywords

Glycemic response, Glycemic index, Obesity, Carbohydrates, Insulin, Blood glucose

Brief summary

This study is designed to investigate associations of low- and high-glycemic load diets with biomarkers of hyperglycemia, hyperinsulinemia and inflammation, potential biomarkers for cancer risk.

Detailed description

This is a randomized, crossover feeding study conducted in normal weight and overweight individuals. Participants will be given all their food to eat and drink (except water) for two 28-day feeding periods (a total of 56 days). The diets will be carefully controlled and energy intake will be regulated to maintain weight stability for each participant. The two feeding periods will be separated by a 28 day washout period when participants will eat their own food. Dinner will be eaten at the Hutchinson Center Monday through Friday. Each evening, breakfast, lunch and snacks will be brought home for the next day. On Friday evenings all the food will be taken home for the weekend. Samples of blood will be collected after an overnight fast at the beginning and the end of each feeding period. All urine will be collected for 24 hours at the end of each feeding period. A number of questionnaires will also be completed during each diet period. A small stool sample will be collected in your own home, before the first feeding period, and once during each feeding period. The stool sample collection is optional. One can decide not to provide a stool sample and still participate in the study.

Interventions

consume both high and low glycemic load diets for 28 days each

consume both high and low glycemic load diets for 28 days each

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy males and female subjects 2. Between the ages of 18 to 45 3. BMI between 18.5 kg/m2 to 24. 9 kg/m2 (normal weight) and between 28.0 kg/m2 to 39.9 kg/m2 (overweight) 4. Willingness to refrain from alcohol during the study 5. Able to come to the FHCRC in Seattle every weekday night for dinner

Exclusion criteria

1. Younger than 18 years of age or older than 45 years of age. 2. Do not fit into one of the study weight groups (normal weight and overweight): BMI \< 18.5 kg/m2 or \> 40.0 kg/m2, and between 25.0 kg/m2and 27.9 kg/m2 3. Have diseases that are treated by diet and/or medications including but not limited to diabetes, kidney disease, heart disease 4. Taking prescription medications every day (this includes women taking birth-control pills, shots, patch or IUD with hormones) 5. Diagnosed with or treated for cancer within the previous five years (except those with a diagnosis and/or treatment of non-melanomatous skin cancer are eligible) 6. Currently pregnant or breastfeeding or planning a pregnancy in the next 3 months. 7. Using any tobacco products on a daily basis (cigarettes, pipes, cigars, chewing tobacco). 8. Using recreational drugs 9. Drinking the following amount of alcohol almost every day: 2 or more cans/bottles of beer OR 2 or more glasses of wine OR 3 or more ounces of hard liquor. 10. Inability (e.g., food allergy or intolerances) or unwillingness to consume the foods that are part of the feeding study diet.

Design outcomes

Primary

MeasureTime frame
The primary endpoints of the study will be a set of inter-related biomarkers for hyperglycemia, hyperinsulinemia and inflammation, potential biomarkers for cancer risk.two 4-week feeding periods (56 days total)

Secondary

MeasureTime frame
Questionnaires will generate data on how these diets may influence mood or depression, sleep habits, and measures of appetite and satiety.two 4-week feeding periods (56 days)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026